HLA DRB1 and HLA DQB1 Alleles in Bulgarian Patients with Primary and Secondary Antiphospholipid Syndrome-Reference-Cited by-同舟云学术

HLA DRB1 and HLA DQB1 Alleles in Bulgarian Patients with Primary and Secondary Antiphospholipid Syndrome

Published:2019-02-01 Issue:1 Volume:46 Page:11-16
ISSN:0324-1750
Container-title:Acta Medica Bulgarica
language:en
Short-container-title:

Author:

Baleva M.¹,Nikolova-Vlahova M.²,Lukanov Tsv.¹,Ivanova-Shivarova M.¹,Karagjozova Zh.³,Martinova F.⁴,Naumova E.¹

Affiliation:

1. Department of Clinical Immunology with Cord Blood Banking , University Hospital “Alexandrovska”, Medical University – Sofia , Bulgaria

2. Department of Nephrology , University Hospital “Alexandrovska”, Medical University – Sofia , Bulgaria

3. Department of Obstetrics and Gynecology , University Hospital “Maychin Dom”, Medical University – Sofia , Bulgaria

4. Laboratory of Clinical Immunology , University Hospital for Emergency Medicine “Pirogov” – Sofia , Bulgaria

Abstract

Abstract Antiphospholipid syndrome (APS) is an autoimmune disease with multifactorial and polygenic pathogenesis. Recently, the genetic predisposition in APS has been subjected to wide discussion. The aim of this study is to determine the prevalence of DRB1 and DQB1 loci in Bulgarian population of healthy persons and patients with primary (PAPS) and secondary (SAPS) APS. Patients are divided in 5 groups: I-29 patents with systemic lupus erythematosus (SLE) with SAPS, II-35 patients with PAPS, III-32 women with spontaneous abortions without aPL, IV-15 patients with different thrombosis (deep venous thromboses, pulmonary embolism, mesenterial thrombosis, myocardial infarction, stroke) without laboratory data for APS, and V-16 SLE patients without clinical and laboratory data for APS. SAPS patients have more frequently DRB1*03 and DQB1*02 and more rarely DRB1*11 and DQB1*03 in comparison with healthy subjects and patients with PAPS. Patents with PAPS, those with spontaneous abortions and patients with thrombotic events but without antiphospholipid antibodies (aPL) have DRB1*03, DRB1*11, DQB1*02 and DQB1*03 alleles similar to the general population. There are no differences between group I (SLE+APS) and group V (SLE) in DRB1* and DQB1*alleles.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Link

https://www.sciendo.com/pdf/10.2478/amb-2019-0002

Reference21 articles.

1. 1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25 (11), 1271-1277.

2. 2. Miyakis S, Lockshin M.D, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Hemost, 2006, 4 (2), 295-306.

3. 3. Castro-Marrero J, Balada E, Vilardell-Tarrés M, Ordi-Ros J. Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol, 2009, 147 (3), 289-296.

4. 4. Kapitany A, Tarr T, Gytvai A, et al. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome. Ann NY Acad Sci, 2009, 1173, 545-551.

5. 5. Trabace S, Nicotra M, Cappellacci S, et al. of HLA-DR and DQ antigens and anticardiolipin antibodies in women with recurrent spontaneous abortions. Am J Reprod Immunol, 1991, 26 (4), 147-149.